ArticleActa pharmaceutica Sinica. B2023

S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung.

Mengyao Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.